Jupiter Life Line Hospitals Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Jupiter Life Line Hospitals Ltd is ₹ 244.25 as of 23 Oct 15:30 . The P/E Ratio of Jupiter Life Line Hospitals Ltd changed from 44.5 on March 2024 to 43 on March 2026 . This represents a CAGR of -1.14% over 3 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Jupiter Life Line Hospitals Ltd changed from ₹ 7853 crore on March 2024 to ₹ 8344 crore on March 2026 . This represents a CAGR of 2.04% over 3 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 467.04 crore as compare to the Jun '26 revenue of ₹ 421.57 crore. This represent the growth of 10.79% The revenue of Molbio Diagnostics Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 411.48 crore. This represent the decline of -100% The ebitda of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 117.39 crore as compare to the Jun '26 ebitda of ₹ 89.86 crore. This represent the growth of 30.64% The ebitda of Molbio Diagnostics Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 103.68 crore. This represent the decline of -100% The net profit of Jupiter Life Line Hospitals Ltd changed from ₹ 44.61 crore to ₹ 56.36 crore over 10 quarters. This represents a CAGR of 9.80% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jupiter Life Line Hospitals Ltd changed from 4.32 % on March 2024 to 3.43 % on March 2026 . This represents a CAGR of -7.40% over 3 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002.
Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multi-speciality tertiary and quaternary care service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,248 across 4 hospitals located in Thane, Pune, Indore & and Dombivli under the 'Jupiter' brand.
The Company has constructing two new multi-speciality hospitals Bibvewadi, Pune (Maharashtra) and in Mira Road, Thane (Maharashtra) with potential capacity of 500 beds and 300 beds respectively.
Company is running a Fortune Park Lake City Hotel in Thane in promoting medical tourism.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Jupiter Life Line Hospitals Ltd and null

Which company has a larger market capitalization, Jupiter Life Line Hospitals Ltd or Molbio Diagnostics Ltd?

Market cap of Jupiter Life Line Hospitals Ltd is 8,007 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Jupiter Life Line Hospitals Ltd and Molbio Diagnostics Ltd?

The stock performance of Jupiter Life Line Hospitals Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jupiter Life Line Hospitals Ltd and Molbio Diagnostics Ltd?

As of October 25, 2026, the Jupiter Life Line Hospitals Ltd stock price is INR ₹244.25. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Jupiter Life Line Hospitals Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Jupiter Life Line Hospitals Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.